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Abstract
Osteoporosis is a metabolic bone disease associated with unequilibrated bone
remodeling resulting from decreased bone formation and/or increased bone
resorption, leading to progressive bone loss. In osteoporotic patients, low
bone mass is associated with an increase of bone marrow fat resulting from
accumulation of adipocytes within bone marrow (BM). BM adipocytes are active
secretory cells, releasing cytokines, adipokines and free fatty acids (FA) that
influence the BM microenvironment and altered the biology of neighboring
cells. Therefore, we examined the influence of palmitate and oleate, two
highly prevalent FA in human organism and diet, on the function and survival
of human mesenchymal stem cells (MSC) and MSC-derived osteoblastic
cells. The saturated FA palmitate exerted a cytotoxic action via initiation of
endoplasmic reticulum stress and activation of the NF-B and ERK pathways. In
addition, palmitate induced a pro-inflammatory response, as determined by the
upregulation of ...
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Osteoporosis is a metabolic bone disease associated with unequilibrated bone remodeling result-
ing fromdecreasedbone formationand/or increasedbone resorption, leading toprogressivebone
loss. In osteoporotic patients, low bone mass is associated with an increase of bone marrow fat
resulting from accumulation of adipocytes within bone marrow (BM). BM adipocytes are active
secretory cells, releasing cytokines, adipokines and free fatty acids (FA) that influence the BM
microenvironment and altered the biology of neighboring cells. Therefore, we examined the
influence of palmitate and oleate, two highly prevalent FA in human organism and diet, on the
function and survival of humanmesenchymal stem cells (MSC) andMSC-derived osteoblastic cells.
The saturated FApalmitate exerted a cytotoxic action via initiationof endoplasmic reticulum stress
and activation of the NF-B and ERK pathways. In addition, palmitate induced a pro-inflammatory
response, as determined by the upregulation of TLR4 expression as well as the increase of IL-6 and
IL-8 expressionand secretion.Moreover,we showed thatMSC-derivedosteoblastic cellsweremore
sensitive to lipotoxicity than undifferentiated MSC. The monounsaturated FA oleate fully neu-
tralized palmitate-induced lipotoxicity by impairing activation of the pathways triggered by the
saturated FA. Moreover, oleate promoted palmitate detoxification by fostering its esterification
into triglycerides and storage in lipid droplets.
Altogether, our data showed that physiological concentrations of palmitate andoleate differently
modulated cell death and function in bone cells. We therefore propose that FA could influence
skeletal health.
Osteoporosis is a metabolic bone disease prevalent inpostmenopausal women and the elderly, associated
with unequilibrated bone remodelling resulting from de-
creased bone formation and/or accelerated bone resorp-
tion. As a result, the refilling of resorption cavities can be
incomplete, leading to progressive bone loss, increased
bone fragility and fracture risk (1).
Bone formation is fulfilled by osteoblastic cells origi-
nating from the bone marrow-derived mesenchymal stem
cells (MSC). MSC are pluripotent progenitor cells able to
differentiate in osteoblastic cells and other cell types such
as adipocytes and chondrocytes (2). Commitment ofMSC
to the osteoblast lineage is controlled by growth factors,
hormones and cytokines and is sensitive to environmental
conditions (3). In osteoporotic patients, the number of
MSC is reduced and is correlated with an increased apo-
ptosis ofMSC and osteocytes (4).Moreover, osteoporosis
is associated with adipocytes accumulation in the bone
marrowniche due to a preferential differentiation ofMSC
toward adipocytes at the expense of osteoblast formation
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(5, 6). Of note, a rise in bone marrow adiposity is also
observed in ageing and, particularly, in secondary osteo-
porosis associated with glucocorticoids therapy or type 2
diabetes mellitus treatments such as PPAR agonists
(7–9).
Adipocytes are integral components of the bone mar-
row but their physiological function in the bone marrow
stem cell niche and the consequence of their excessive ac-
cumulation in pathological entities remains elusive (10).
Although they have long been considered as inert cells, it
is now widely accepted that adipocytes constitute a met-
abolically activedepot thatmayaffect skeletalmetabolism
(11–14). By releasing factors such as fatty acids (FA), adi-
pokines and cytokines, marrow adipocytes may generate
a local microenvironment that could disturb bone cells
viability and function (13, 15, 16). If the impact of cyto-
kines andadipokines onbonehealthhas beenassessed, the
effects of FA on the biological function and survival of
MSC and osteoblastic cells have not yet been properly
studied.
In physiological conditions, FA serve as key sources of
cellular metabolic fuel and an acute exposure to these nu-
trients is usually beneficial for mammalian cells. Yet, a
chronic exposure to FA may lead to ectopic lipid deposi-
tion in cells of nonadipose tissue. This unsuited FA accu-
mulation is now increasingly recognized to contribute to
organ injury through a process termed lipotoxicity (17).
Sensitivity to lipotoxicity differs across cell types. In myo-
cytes, hepatocytes and insulin-producing pancreatic beta
cells, excessive FA availability results in cellular dysfunc-
tion and death (18–20), leading to disease states (17). If
the contribution to lipotoxicity of long chain saturated
and unsaturated FA varies depending on the cell type, FA
toxicity is however often associated with the saturated
ones (21).
We postulated that, in the setting of osteoporosis, ex-
cessive adipocytes accumulation in thebonemarrowniche
may favor the local release of larger quantities of saturated
FAwhich could interferewithbone cells homeostasis.This
hypothesis is supported by both in vitro and in vivo ob-
servations. Human primary coculture experiments of adi-
pocytes originating from mammary adipose tissue and
MSC-derived osteoblasts have shown that adipocytes lib-
erate factors that inhibit preosteoblast proliferation and
differentiation (22, 23). In a similar experimental model,
MSC-derived adipocytes enhanced osteoblastic cells apo-
ptosis via the release of saturated FA (24, 25). Recently,
the study ofYeung et al demonstrated that the highermar-
row fat content observed in osteoporotic subjects is char-
acterized by an increased ratio of saturated vs unsaturated
FA (26).Moreover, in diabetic patients, the proportion of
saturated vs unsaturated FA in the marrow fat was asso-
ciated with modifications of the fracture risk (27). Addi-
tionally, it is well known that diet FA profile (saturated,
mono- or polyunsaturated) influences the FAprofile of the
triglycerides stored in adipocytes. Indeed, a higher con-
sumption of saturated FA is negatively associated with
bone mineral density (BMD) (28) and is linked to an in-
creased risk of osteoporotic fractures (29).
The purpose of this study was therefore to examine the
influence of FA on the function and survival of human
MSC and osteoblastic cells. We selected two FA widely
represented in human blood and diet (30): palmitate
(Palm), a saturated FA (C16:0) and oleate (Ole), a mono-
unsaturated one (C18:1 n-9). Palm and Ole have been
extensively used in previous studies to evaluate the effects
of FA on various cell types (31–33).
Our data showed that physiological concentrations of
the two FA differently regulated cell death and function.
Materials and Methods
Isolation, culture and characterization of human
MSC and MSC-derived osteoblastic cells
Human MSC were obtained from bone marrow aspirated
fromtheposterior iliac crest of healthydonors (18–50yearsold).
Our local institutional ethical committee approved the study and
all subjects gave their written consent. Bonemarrowwas diluted
1:0.5 with PBS and overlaid on Ficoll-Paque PREMIUM (GE
Healthcare, Diegem, Belgium). Mononuclear cells were isolated
after centrifugationand seededat adensity of 5.7104 cells/cm2
in DMEM low glucose (1 g/l; Invitrogen, Gent, Belgium) sup-
plemented with 10% FBS (Sigma-Aldrich, Diegem, Belgium),
100 U/ml penicillin and 100 g/ml streptomycin (Invitrogen).
The culturemediumwas renewedafter 4days of culture and then
every 2–3 days until cells reached confluence. MSC were de-
tached by enzymatic treatment (Trypsin-EDTA; Invitrogen) ev-
ery week and successively seeded at a density of 5.7 103 cells/
cm2 until passage 8.
To confirm themesenchymal nature of the isolated cells, phe-
notyping by FACS flow cytometer and differentiation assays
were performed. Cells were stained with the following antibod-
ies: CD34-PE, CD45-FITC and CD73-PE from BD Biosciences
(San Jose, USA), CD90-APC, CD105-FITC, andALP-APC from
R&DSystems (Abingdon,UnitedKingdom) (34).We confirmed
that the cells expressed CD73, CD90, and CD105, and were
negative for CD34, CD45 and ALP (Suppl. Figure 1A and B).
Fluorescence was measured on a FACSCanto II flow cytometer
(BD Biosciences) and data were processed using Diva software
v5.0. At least 10 000 events were acquired for each sample. Sup-
plemental validation showed that the cells had the capacity to
differentiate in the osteoblastic and adipogenic lineagewhen cul-
tured in standard in vitro differentiation assays (see below).
To obtain humanMSC-derived osteoblastic cells (Ob), MSC
were cultured for 14 days in an osteogenicmedium (DMEM low
glucose containing 10% FBS, 100 U/ml penicillin, 100 g/ml
streptomycin, 10 mM ß-glycerophosphate (Sigma-Aldrich), 10
nMdexamethasone (Sigma-Aldrich) and 50g/ml ascorbic acid
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(Sigma-Aldrich). The culturemediumwas renewed every 2 days.
The osteogenic medium was then replaced by standard culture
medium for 48h. Osteoblastic differentiation was validated be-
fore FA treatment by mineralization assay (alizarin red staining)
andmeasurement of alkaline phosphatase activity (ALP), as pre-
viously described (Suppl. Figure 1C) (35, 36). Induction of the
osteoblastic differentiationmarker genesRunt-related transcrip-
tion factor 2 (Runx2) and Osteocalcin (OCN) was also con-
firmed by qPCR (Suppl. Figure 1D).
For adipogenic differentiation, MSC were cultured for 14
days in an adipogenic medium (DMEM low glucose containing
10% FBS, 100 U/ml penicillin, 100 g/ml streptomycin, 60 M
indomethacin (Sigma-Aldrich), 0.5 mM 3-isobutyl-1-methylx-
anthine (Gibco), 5 g/ml insulin (Sigma-Aldrich) and 100 nM
dexamethasone (Sigma-Aldrich). The culture medium was re-
newed every 2 days. Adipogenesis was evaluated by Oil Red
staining as previously described (Suppl. Figure 1C) (25).
SaOS-2 cells, a human osteoblastic cell line (a kind gift from
Bone Therapeutics, Gosselies, Belgium) were grown inMcCoy’s
5Amedium (Invitrogen) supplementedwith 10%FBS, 100U/ml
penicillin and 100 g/ml streptomycin.
Free fatty acid treatment
Sodium oleate and sodium palmitate (Sigma-Aldrich) were
solubilized in 90% ethanol at 70°C to obtain 50 mM stock so-
lutions. For FA supplementation experiments, cells were cul-
tured for the indicated times in a FA-specific medium composed
of DMEM low glucose (for MSC) or McCoy’s 5A medium (for
SaOS-2 cells) supplemented with 1% FBS, 100 U/ml penicillin,
100 g/ml streptomycin, 1% FA free bovine serum albumin
(BSA; Sigma-Aldrich) and, when required, diluted Palm and/or
Ole (0.125 to 0.50 mM). Of note, a similar dilution of ethanol,
the FA solvent, was added in the control condition (eg, absence
of FA). Taking into account the stepwise equilibriummodel and
the respective binding affinities of PalmandOle for BSA (37), the
concentrations of FA used in our study are close to the physio-
logical ones (30).
Determination of cell viability
Cells were seeded in 96-well plates at a density of 14.7 103
cells/cm2 forMSC andOb, and 20.6 103 cells/cm2 for SaOS-2
cells.After 3days, culturemediawere replacedby theFA-specific
medium without or with increasing concentrations of Palm
and/orOle for the indicated times and concentrations.Cellswere
incubated for 15 minutes with the nuclear binding dyes pro-
pidium iodide (PI, 10g/ml, Sigma-Aldrich) andHoechst33 342
(HO342, 10g/ml, Sigma-Aldrich). Cell viabilitywas examined
by inverted microscopy (Axiovision Zeiss, Zaventem, Belgium)
with UV excitation ( excitation/emission: 365/397 nm). Viable
cells were characterized by their intact nuclei with blue fluores-
cence while dead cells were depicted by yellow-red fluorescence.
In each experimental condition, a minimum of 600 cells were
counted.
Measurement of caspases-3/7 activity
Caspases-3/7 activity was determined using the Caspase-
Glo® 3/7 assay (Promega, Leiden, TheNetherlands). 29.4 103
cells/cm2 were seeded in 96-well white plates. After 3 days, cul-
ture media were replaced by FA-specific medium supplemented
with increasing concentrations of Palm, complemented or not
with Ole, for the indicated times. At the end of the incubation
period, 100 l of culture medium were replaced by 100 l of
Caspase-Glo reagent resulting in cell lysis and cleavage of the
Caspase-Glo® 3/7 substrate by the activated caspases. The lu-
minescent signal generated was detected after 1 hour using a
Victor2 (PerkinElmer, Zaventem, Belgium). Staurosporin 1 M
(Sigma-Aldrich) was used as positive control.
Measurement of NF-B activation
SaOS-2 cellswere plated in 8-chamber slides (BDBiosciences)
at a density of 14.5 103 cells/cm2. After 3 days, culture media
were replaced by FA-specific medium supplemented with Palm
and/or Ole, for the indicated times. Cells treated for 1 hour with
30 UI/ml recombinant human (rh) IL-1 (R&D systems) were
used as positive control. To evaluate NF-B nuclear transloca-
tion by immunocytochemistry, cells were fixed with 4% form-
aldehyde for 10 minutes, and permeabilized with an acetone/
methanol (7:3) mixture for 5 minutes. Nonspecific binding sites
were blocked with 10% normal goat serum (Gibco, Gent, Bel-
gium) and 0.8%BSA fraction V (Sigma-Aldrich) for 30minutes.
Cells were then incubated overnight with rabbit polyclonal an-
tibody raised against NF-B p65 (1:500, Santa Cruz Biotech-
nology, Heidelberg, Germany). Finally, cells were incubated for
1 hour with donkey antirabbit IgG-fluorescein isothiocyanate
(FITC), (1:200, Jackson IR, Newmarket, United Kingdom) and
nuclei were stained with HO 342. Cells were mounted using the
Dako fluorescence mounting medium (Dako, Heverlee, Bel-
gium) and examined with inverted fluorescence microscope
(Axio Zeiss).
Our results were confirmed in SaOS-2 andMSC extract sam-
ples, using a NF-B p65 ELISA kit following the manufacturer’s
instructions (Fisher Scientific, Aalst, Belgium).
Quantification of mRNA expression by
quantitative polymerase chain reaction (PCR)
(qPCR)
TotalRNAwas isolated fromMSC,Obcells and SaOS-2 cells
seeded for 3 days before treatment in 6-well plates at a density of
10.4 103 cells/cm2, using AURUMTM kit (Bio-Rad, Nazareth
Eke, Belgium) according to the manufacturer’s protocol. Total
Table 1. Antibody Table
Peptide/protein target Antigen sequence (if known) Name of Antibody
Manufacturer, catalog #, and/or
name of individual providing the antibody
Species raised in;
monoclonal or polyclonal Dilution used
Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) Antibody Cell Signaling, #9101 Polyclonal 1/1000
p44/42 MAPK (Erk1/2) / Anti-MAP Kinase 1/2 (Erk1/2), CT MILLIPORE, #06–182 Polyclonal 1/1000
Phospho-eIF2 (Ser51) Phospho-eIF2 (Ser51) (D9G8) XPTM Rabbit mAB Cell Signaling, #3398 Monoclonal 1/1000
eIF2 / eIF2 (D7D3) XPTM Rabbit mab Cell Signaling, #5324 Monoclonal 1/1000
NF-B / NF-B p65 (C-20) Santa Cruz, sc-372 Polyclonal 1/500
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RNA was reverse transcribed using iScriptcDNA synthesis kit
(Bio-Rad).
qPCR reactions were performed using a CFX96 thermal sys-
tem (Bio-Rad) in a total reaction volume of 20 l containing 3
mMMgCl2, 0.3 M (each) forward and reverse primers (Euro-
gentec, Seraing, Belgium), 10l SYBRGreenmix (Bio-Rad), and
2l cDNA (10 ng/l). The cycling programwas as follow: 95°C
for 3 minutes followed by 40 cycles at 95°C for 30 seconds and
60°C for 30 seconds. All reactions were performed in duplicate.
Expression of Toll-like receptor-4 (TLR4) was quantified by
qPCR using the standard curvemethod (38) and the appropriate
primer sets (Supplementary material, Table 1). Relative mRNA
expression of the other target genes was evaluated using the
comparative threshold cycle method (2-Ct) and adequate
primer sets (Supplementary material, Table 2). Hypoxanthine
phosphoribosyltransferase 1 (HPRT1) was used as housekeep-
ing gene.
To study X-box binding protein 1 (XBP1) splicing, cDNA
were amplified by standard PCR (cycling program: 94°C for 45
seconds, 58°C for 20 seconds and 72°C for 1 minute; 24 cycles)
using XBP1 specific primers (Supplementary material, Table 1).
XBP1 expressionwas normalized forHPRT1 expression. Tenl
of the PCR reaction mixture were analyzed on a 2% agarose gel
and bands were visualized using Fusion UV System equipment
(Vilber Lourmat, Marne-La-Vallée, France).
Western blotting
HumanMSCtreatedwithFAwere lyzedwithLaemmli buffer
(10% glycerol, 0.5 mM DTT, 63 mM Tris-HCl, 1% SDS, pH
6.8) containing a cocktail of proteases and phosphatases inhib-
itors (Roche Diagnostics, Vilvoorde, Belgium). Proteins were
quantified by a paper dye binding assay. Equal protein amounts
were separated by SDS-PAGE using 10% or 12% polyacryl-
amide gels. Proteins were transferred on polyvinylidene difluo-
ride (PVDF)membranes Immobilion-P (Millipore,Overijse, Bel-
gium) and immunolabeled overnight at 4°C using the following
antibodies: anti-phospho-eIF2Ser51 and anti-phospho-ERK-
Thr202/Tyr204 (Cell Signaling Technology, Bioké, Leiden, The
Netherlands). The secondary antibodies peroxidase-conjugated
ECLTM (GE healthcare) were used for 1 hour at room temper-
ature. The immune complexes were detected by using the en-
hanced chemiluminescence method (Western Lightning® Plus-
ECL, PerkinElmer Inc, Zaventem, Belgium). Band densitieswere
quantified by ImageJ program (NIH, Bethesda, USA). Results
were expressed as relative ratio between the phospho- and the
total proteins, which were detected with the following antibod-
ies: anti-eIF2 (Cell Signaling Technology) or anti-ERK
(Millipore).
Measurement of IL-6 and IL-8 production
Supernatants of MSC were collected after 48 hours of treat-
ment with FA, aliquoted and frozen at –20°C until use. IL-6 and
IL-8 concentrations were measured by ELISA according to the
manufacturer’s protocol (DuosetTM, R&D systems).
Detection of intracellular lipid droplets (LD) and
characterization of their neutral lipids content
After 16hours incubationwith FA, SaOS-2 cellswerewashed
twice with PBS and fixed with 4% paraformaldehyde for 15
minutes. Neutral lipids accumulated in intracellular LD were
stained with Oil Red O (Sigma-Aldrich) for 2 hours and rinsed
twice with PBS before microscopic observation. To evaluate the
cellular content of neutral lipids, cells were washed with PBS,
scrapped and collected in 1 ml lysis buffer (1% SDS, 60 mM
Tris-HCl and 10 mM EDTA). Total lipids were extracted with
chloroform/methanol/water (2:2:1). Isolation of cellular neutral
lipids and analysis of their FA contentwere performed according
to Louis et al 2014 (39).
Statistical analysis
Data are presented asmeans SEM.Valueswere determined
from at least three independent experiments. Statistical analysis
was performed using Student’s t test or one-way ANOVA fol-
lowed by t test with the Bonferroni correction for multiple com-
parisons. Differences between groups were considered as statis-
tically significant at P  .05.
Results
Oleate prevents palmitate-induced lipotoxicity
To evaluate the sensitivity of human MSC and Ob to
lipotoxicity, cells were exposed to increasing concentra-
tions of Palm (0.125 to 0.50 mM) and/or Ole (0.25 mM)
for 24 to 72 hours. Palm elicited cell mortality in a time-
and dose-dependent manner in both cell types and our
data demonstrated that Ob were more sensitive to lipo-
toxicity thanMSC. Indeed, as showed in Figure 1A and B,
a treatment for48hourswith0.50mMof the saturatedFA
reduced cell viability to 50  3.9% in MSC (P  .001 vs
Ctrl) and to 11.8 3.4% inOb (P .001 vs Ctrl). Similar
observations were obtained in SaOS-2 cells (Suppl. Figure
2A). By contrast, Ole did not affect cell viability (data not
shown) but, rather, completely prevented the harmful ef-
fect of Palm (Figure 1A and B). The cytoprotective action
of Ole was maintained even when the culture period was
extended to 7 days andwhen the concentration ofOlewas
decreased to 0.05 mM (data not shown).
To determine whether cell death was associated with
apoptosis, caspases-3/7 activity was evaluated after 24
hours and 48 hours of treatments. Palm toxicity coincided
with a dose- and time-dependent increase of caspases-3/7
activity inMSC(Figure1C).Thebeneficial effect ofOleon
Palm cytotoxicitywas reflected by a complete suppression
of caspases activation,which persisted evenwhenOlewas
tested at 0.05 mM (Figure 1C). Similar results were ob-
tained in SaOS-2 cells (Suppl. Figure 2B) and Ob (Suppl.
Figure 2C).
Oleate abolishes palmitate-induced ERK and NF-B
activation
ERK and NF-B pathways control cell survival. We
therefore evaluated the effects of Palm and Ole on ERK
activation. Our results showed that Palm stimulated ERK
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phosphorylation in MSC which was suppressed by addi-
tion ofOle (Figure 2A). Similar results were obtainedwith
SaOS-2 cells (Suppl. Figure 3).
Inparallel,we evaluated the effect ofPalmonactivation
of NF-B, a transcription factor ensuring a proapoptotic
role in Ob (40). As illustrated in Figure 2B, Palm stimu-
lated NF-B nuclear translocation in SaOS-2 cells, which
did not occur when Palm was asso-
ciated with Ole. Similar results were
obtained in MSC by ELISA (Suppl.
Figure 4).
Oleate blocks palmitate-induced
proinflammatory response
In immune cells, the activation of
NF-B and ERK pathways induces
an inflammationprocess through the
transcriptional regulation of cyto-
kines and chemokines. MSC are
known to secrete soluble factors in
response to stress conditions such as
hypoxia or hyperglycemia (41, 42).
However, little information is avail-
able concerning the effects of Palm
and Ole on cytokines regulation in
MSC and Ob. Our results showed
that, after 24 hours of treatment,
Palm triggered IL-6 (Figure 3A) and
IL-8 (Figure 3B) expression in MSC
and Ob, while it did not affect
chemokine (C-C motif) ligand 2
(CCL2,MCP1) expression (data not
shown). Of note, Palm-induced cy-
tokines expression was higher in Ob
than in MSC (Figure 3A & B). Co-
incubation of the saturated FA with
Ole prevented IL-6 and IL-8 gene up-
regulation in both cell types (Figure
3A&B). In parallel, we assessed IL-6
and IL-8 secretion in MSC. Palm
triggered the secretion of both cyto-
kines, which was abrogated by Ole
(Figure 3C), as observed for gene
expression.
TLRs detect exogenous patho-
gen-associated molecular patterns
and initiate cytokines and chemo-
kines secretion via ERK and NF-B
pathways activation. Interestingly,
TLR4 is also able to trigger immune
responses after the detection of en-
dogenous ligands such as the long
chain FA Palm and stearate (43).We
observed that, after 24 hours of
treatment, Palm increased dose-de-
pendently TLR4 expression in MSC
Figure 1. Oleate suppressed palmitate-induced cytotoxicity in MSC and Ob. MSC (A,C) and Ob
(B) were treated with increasing concentrations of Palm (0.125 mM to 0.50 mM)  Ole (0.05
mM or 0.25 mM) for the indicated times. (A,B) Cell viability was quantified by nuclear staining
with Hoechst and propidium iodide. Values are mean  SEM of 15 (MSC) or 5 (Ob) individual
experiments. **P  .001 vs appropriate control condition (Ctrl, 24, 48 or 72 hours); ##P  .001
vs 0.25 mM Palm. C, Caspases-3/7 activity was measured using the Caspases-3/7 Glo assay.
Values are expressed relative to Ctrl and are mean  SEM of 7 individual experiments. *P  .01,
**P  .001 vs appropriate control (Ctrl, 24 or 48 hours); #P  .01 vs 0.25 mM Palm.
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and, to amoremarked extent, inOb (Fig. 4).Ole alone did
not alter TLR4 expression (data not shown) but repressed
Palm-induced gene up-regulation (Fig. 4). Similar data
were obtained in SaOS-2 cells (data not shown). There-
fore, to examine the contribution of TLR4 in Palm-in-
duced lipotoxicity, we used MSC isolated from Warthon
jelly (WJ-MSC) as they do not express TLR4 (44). We
observed thatWJ-MSCwere as susceptible to lipotoxicity
as MSC isolated from bone marrow
(Suppl. Figure 5).
Oleate abrogates palmitate-
induced endoplasmic reticulum
(ER) stress activation
ER stress was recently implicated
in Palm-induced apoptosis in human
MSC (45). Therefore, we evaluated
whether the protective action of Ole
could be mediated through preven-
tion of ER stress initiation in MSC
and Ob by different approaches.
First, we measured the expression
levels of well-known ER stress
marker genes such as the transcrip-
tion factors C/EBP homologous pro-
tein (CHOP), activating transcrip-
tion factor 4 (ATF4) andXBP1.A24
hours treatment with Palm up-regu-
lated the expression of the selected
genes in both MSC and Ob (Figure
5A-C). Interestingly, the impact of
the saturated FA on gene expression
was more marked in Ob than in
MSC. Moreover, Palm activated the
cleavage of XBP1 mRNA (Fig. 5D).
Ole abolished Palm-induced gene
up-regulation and XBP1 splicing in
both cell types (Figure 5).
Secondly, we evaluated the acti-
vation of the unfolded protein re-
sponse (UPR), a signaling network
initiated in response to severe ER
stress.The shut-downofprotein syn-
thesis was assessed by measuring the
phosphorylation of the alpha sub-
unit of the eukaryotic initiation fac-
tor 2 (eIF2) and the expression of the
Ca2-sensitive chaperone binding
immunoglobulin protein (BiP) was
determined by qPCR. Our results
demonstrated that Palm treatment
led to overexpression of BiP (Figure
6A) and increased eIF2 phosphor-
ylation inMSC(Fig. 6B-C).Addition
of Ole suppressed BiP expression
(Fig. 6A) and restored eIF2 phos-
Figure 2. Oleate blocked palmitate-induced activation of ERK and NF-B. A, MSC were treated
for 48 hours with 0.25 mM Palm  0.25 mM Ole. ERK phosphorylation was evaluated by
Western blotting and normalized for total ERK. The western blot is representative of 1 out of 4
individual experiments. Values are mean  SEM. *P  .05 vs Ctrl, #P  .05 vs 0.25 mM Palm. B,
SaOS-2 cells were treated with 0.50 mM Palm or 0.25 mM Palm plus 0.25 mM Ole. Nuclear
translocation of NF-B was regularly evaluated by immunocytochemistry. Values presented as the
percentage of stained nuclei are means  SEM of 6 individual experiments. Representative
immunocytochemistry results of NF-B nuclear translocation. IL-1 was used as positive control.
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phorylation to its control levels (Fig. 6B-C). Similar results
were obtained in SaOS-2 cells (data not shown).
Oleate, but not palmitate, induces lipid droplets
formation
In situations of excessive FA exposure, triglycerides
(TG) may accumulate in intracellular LD that have now
gain recognitionasdynamicorganelles involved in various
cellular processes (46). We therefore evaluated the capac-
ity of Palm andOle to induce LD for-
mation in osteoblastic cells. As illus-
trated in Figure 7A, after 16 hours of
treatment, SaOS-2 cells cultured in
control conditions or in the presence
of Palm did not present LD. How-
ever, Ole, tested alone or in the con-
comitant presence of Palm, triggered
LD formation (Figure 7A). We fur-
ther quantified and characterized the
neutral lipids content (mainly com-
posed of mono-, di-, and TG) of
SaOS-2 cells exposed to Palm and/or
Ole (Figure7B). In the absenceofFA,
the cellular neutral lipids content
amounted to 3.4 1.4 g/106 cells.
Increased concentrations of Palm
(0.125 mM to 0.50 mM) tended to
augment (P  .08) the cellular neu-
tral lipids content whereas 0.25 mM
Ole was sufficient to induce a 7.3-
fold increase (P .018) of total neu-
tral lipids (Figure 7B). When com-
pared to 0.25 mM Ole alone, the
concomitant presence of Palm and
Ole (0.25 mM each) did not modify
the total lipid content. Nevertheless,
when compared to 0.25 mM Palm,
the addition of Ole increased by 3.4
fold the incorporation of Palm into
the neutral lipids fraction (P .001;
Figure 7B).
Discussion
Fat is an integral component of the
bonemarrowmicroenvironment but
its physiological function and its role
in the pathogenesis of metabolic
bone diseases are still under debate.
In osteoporotic patients and in the
context of ageing, an inverse relation
between marrow adipose tissue
(MAT) and bone mass is now well
established (47, 48).However, in an-
Figure 3. Oleate prevented IL-6 and IL-8 expression stimulated by palmitate. MSC and Ob were
treated for 24h with increasing concentrations of Palm (0.25 mM to 0.50 mM)  0.25 mM Ole.
IL-6 (A) and IL-8 (B) expression were quantified by qPCR using the CT method compared to
Ctrl. Values were normalized for HPRT1 expression and are represented as means  SEM of 6
individual experiments. *P  .01, **P  .001 vs Ctrl, #P  .01, ##P  .001 vs 0.25 mM Palm. C,
IL-6 and IL-8 secretions were quantified in supernatants of MSC treated 48 hours with 0.25 mM
Palm  0.25 mM Ole using ELISA kit. Values were normalized for 100 000 cells and are
represented as means  SEM of 7 individual experiments. *P  .05 vs Ctrl, #P  .05, ##P  .01
vs 0.25 mM Palm.
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imal models, obesity or a high fat diet may trigger various
bone responses ranging from preserved bone density (49)
to decreased bone mass and quality (50–52). In humans,
obesitywas previously often correlatedwith a higher bone
mass density (53, 54) but it may also adversely alter bone
quality and contribute to an increased fracture risk (55,
56). Recent studies demonstrate that bonemass andMAT
are inversely correlated inhealthy subjects (57, 58).On the
whole, these data demonstrate the complexity of the re-
lationship between exogenous lipid intake, MAT and
bone health. Of note, the concept that the FA profile as
well as the amount of marrow adipocytes may be relevant
for skeletal preservation is emerging (59, 60).
Recent experimental data suggest that FA and lipotox-
icity could play a role in the initiation and/or evolution of
metabolic bone diseases such as osteoporosis.
In the present studywe evaluated the effect of Palm and
Ole, the most common saturated and monounsaturated
FA found in human serumand in theWestern diet (30).Of
note, Palm was recently identified as one of the FA pre-
dominantly liberated in the culture medium by MSC-de-
rived adipocytes (25). The effect of Palm and Ole were
extensively studied in cell types implicated in disorders of
energy metabolism (ie, hepatocytes, insulin-producing
pancreatic beta cells, myocytes). However, the concept of
lipotoxicity recently emerged in skeletal cells and the few
studies conducted on human bone marrow-derived MSC
and MSC-derived osteoblastic cells focused on the action
of Palm (25, 31, 35, 36, 45). The studies addressing the
effect ofOle are rare and diverging.While the recent work
of Fillmore et al (61) demonstrated that Ole abrogated
Palm-induced impairment of MSC metabolism, two pre-
vious studies indicated thatOle is toxic forMSC, does not
prevent Palm-induced toxicity and increases Palm-trig-
gered apoptosis (31, 62).
We demonstrated that Palm and Ole inversely regulate
cell death and function of human MSC and osteoblastic
cells.Weconfirmed thatPalmelicits cell deathand showed
Figure 4. Oleate abolished palmitate–induced expression of TLR4.
MSC and Ob were treated for 24 hours with Palm (0.25 mM to 0.50
mM)  0.25 mM Ole. TLR4 expression was quantified by qPCR using
standard curve method and normalized for HPRT1.Values are mean 
SEM of 6 individual experiments. *P  .05, **P  .01 vs Ctrl; #P 
.05, ##P  .01 vs Palm 0.25 mM.
Figure 5. Oleate blocked ER stress markers expression and activation
of palmitate-induced XBP splicing. MSC and Ob were treated for 24h
with 0.25 mM Palm  0.25 mM Ole. CHOP (A), ATF4 (B) and XBP1 (C)
expression were quantified by qPCR using the CT method. Values
were normalized for HPRT1 expression and are expressed as the CT
compared to Ctrl. Results are means  SEM of 6 individual
experiments. * P  .05, ** P  .01, *** P  .001 vs Ctrl; # P  .05,
## P  .01, ### P  .001 vs Palm 0.25 mM. D, Representative PCR
results for XBP1 splicing, compared to HPRT1 expression, of 1 out of 6
individual experiments in MSC.
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that Ob are more sensitive to lipotoxicity than MSC. We
established that the monounsaturated FA Ole is not toxic
for MSC and osteoblastic cells but that it completely ab-
rogates Palm-induced lipotoxicity and proinflammatory
response.
Depending on the cell type, lipotoxicity is related to the
initiation of different cellular mechanisms (21). We thus
further clarified themolecularmechanisms underlying the
cytotoxic andcytoprotective actionsof the twoFA inMSC
and osteoblastic cells since their understanding may pave
the way for innovative therapeutic approaches.
ERK activation may lead to cell death or survival. A
recent study showed that Palm activates ERK phosphor-
ylation in MSC (45), while contradictory data were ob-
tained in osteoblastic cells (31, 35). We showed that Palm
triggers ERK phosphorylation in MSC and osteoblastic
cells; Ole does not affect ERK pathway but prevents its
activation by Palm. Furthermore, we demonstrated that
Palm activates the transcription factor NF-B, a phenom-
enon counteracted by Ole. NF-B plays a proapoptotic
role in osteoblastic cells and its activation was associated
with lipotoxicity-induced ER stress in other cell types (40,
63). Thus, Ole could protect MSC and Ob from Palm-
induced lipotoxicity by preventing the initiation of two
proapoptotic pathways.
In MSC, ERK and NF-B pathways regulate cytokines
and chemokines secretion and can be activated following
TLRs stimulation by exogenous ligands. The effects of FA
on cytokines production and TLRs expression have not
yet been investigated in human MSC and osteoblastic
cells. We showed that Palm triggers TLR4, IL-6 and IL-8
expression and secretion that were completely suppressed
byOle. Palm-induced cytokines andTLR4expressionwas
higher in Ob than in MSC. Chronic inflammation is as-
sociated with aging and induces bone loss and osteopo-
rosis (64). Interestingly, a growing number of studies re-
lated to metabolic diseases points to a link between
enhanced circulating FA levels and the induction of a
chronic inflammatory process via TLRs stimulation (65).
TLRs perpetuate inflammatory responses through the rec-
ognition of exogenous pathogen-associated molecular
patterns and endogenous ligands. For example, TLR4 is
able to trigger immune responses after the detection of
long chain FA (43). MSC constitutively express the pro-
inflammatory cytokines IL-6and IL-8.However, theover-
production of these cytokines stimulates the differentia-
tionof osteoclast precursor cells tomature osteoclasts (66,
67). By enhancing IL-6 and IL-8 production, Palm could
thus promote a proinflammatory state favoring bone re-
sorption and impairing bone formation. In line with this
hypothesis, IL-6 and IL-8 levels are increased in both the
synovial fluid and the serum of patients suffering from
chronic inflammatory diseases predisposing to osteopo-
rosis (68, 69).
To clarify the role of TLR4 in Palm-induced lipotox-
icity, we used WJ-MSC that do not express TLR4 (44).
WJ-MSC were as susceptible to Palm as MSC isolated
from bone marrow, suggesting that TLR4 does not me-
diate lipotoxicity inMSCand osteoblastic cells.However,
TLR2 may also recognize FA (43). TLR2 is expressed in
WJ-MSC (44) and we observed that it is upregulated by
Palm (data not shown). Therefore, the functional role of
Figure 6. Oleate prevented palmitate-triggered eIF2 activation and
BiP expression. MSC were treated for 24 and 48 hours with increasing
concentrations of Palm (0.25 mM to 0.50 mM)  Ole 0.25 mM. A, BiP
expression was quantified by qPCR using the CT. Values were
normalized for HPRT1 expression and are expressed as the CT
compared to the control (Ctrl). Results are mean  SEM of 6 individual
experiments. B, Expression of phosphorylated eIF2 was evaluated by
Western blotting and normalized for total eIF2. Values are mean 
SEM. **P  .001 vs Ctrl, ##P  .001 vs Palm 0.25 mM. C, The
Western blotting figure is representative of 1 out of 4 individual
experiments.
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TLR4 and/or TLR2 in Palm-induced lipotoxicity should
not be excluded and requires further investigations.
Saturated FA are major ER-stress inducers in pancre-
atic beta cells (70) and it has recently been shown that
FA-inducedMSC apoptosis implicate ER stress activation
(45). Altogether, our results showed that Palm triggered
ERstress andUPR inbothMSCandosteoblastic cells. The
ER stress response is more severe in Ob, which correlates
Figure 7. Oleate but not palmitate, enhanced lipid droplets formation and promoted palmitate incorporation into the neutral lipids fraction.
SaOS-2 cells were treated for 16 hours with increasing concentrations of Palm (0.125 mM to 0.50 mM)  0.25 mM Ole. A, Lipid droplets were
identified by Oil Red staining. B, Total cellular neutral lipids content and FA composition were evaluated by gas chromatography. Values are
expressed relative to Ctrl and are means of 3 individual experiments.
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with their higher susceptibility to lipotoxicity. Moreover,
we established thatOle exerts its protective actionbyabol-
ishing Palm-induced ERdysfunctions. The ERplays a piv-
otal role in the regulation of lipid and proteinmetabolism.
The accumulation ofmisfolded proteins or other stressors
in the ER initiates a cellular adaptive program, known as
the UPR, to re-establish the cellular equilibrium:while the
inhibition of general protein synthesis prevents further
overloading of the ER, the simultaneous production of
specific chaperones favors the refolding of misfolded pro-
teins. However, prolonged or extreme ER stress over-
whelms the normalERprotein foldingmachinery, triggers
activation of proapoptotic genes and leads to cell death
(63).
In situations of excessive FA exposure, the relative tox-
icity of FA is related to their capacity to be directed to
distinct metabolic fates. For example, palmitoylation was
recently implicated in Palm-induced toxicity in human os-
teoblasts (36). On the other hand, it it is known that Palm
is poorly incorporated into TG and causes apoptosis
whereas Ole stimulates TG accumulation and is well tol-
erated. Monounsaturated FA thus promote the detoxifi-
cation of saturated FAby fostering their esterification into
TG so that the potentially toxic lipids are safely stored
within LD (71). LD formation in nonadipose cells in re-
sponse to lipid overload was therefore proposed as an
initial cellular defense against lipotoxicity (72).The role of
TG accumulation in cell survival is however somewhat
controversial. In the insulin producing pancreatic beta
cells, it was described as cytotoxic (73) or cytoprotective
(37).
We thus evaluated the capacity of Palm and Ole to
induce LD formation in osteoblastic cells. Ole, but not
Palm, triggers LD formation and increases the cellular
neutral lipids content.Moreover, in the concomitant pres-
enceof Palm,Ole favors the incorporationof the saturated
FA into theneutral lipids fraction.Theseobservations sug-
gest thatOle promotes FA storage andmay therefore serve
its protective function by favoring Palm esterification and
incorporation into stable LD.
In conclusion, several pathways are involved in Palm-
induced toxicity inhumanMSCandosteoblastic cells.The
lipotoxic action exerted on osteoblastic cells by Palm is
prevented by the monounsaturated FA Ole via induction
of TG synthesis and inhibition of ERK activation and ER
stress initiation. In addition, Palm, but not Ole has a pro-
inflammatory effect that may compromise bone health.
Interestingly, Drosatos-Tampakaki et al has recently
shown that Palm is not toxic for osteoclasts, the bone
resorbing cells and enhances osteoclastogenesis, thus fa-
voringbone resorption (74).On the contrary,Oledoesnot
support osteoclast differentiation but inhibits Palm-in-
duced osteoclastogenesis by increasing TG accumulation
and inducing LD formation (74).
The present study, combined with the work of Drosa-
tos-Tampakaki et al, demonstrates that saturated and
mono-unsaturated FA have opposite actions on osteo-
blasts and osteoclasts. Therefore,while Palm could impair
bone formation and promote bone resorption, Ole could
have a protective action on bone cells by counteracting
those effects. Further studies should now be pursued in
animalmodels of bonediseases associatedwith alterations
of lipid metabolism, such as osteoporosis, to establish the
impact of FA on bone mass and evaluate whether the ma-
nipulation of dietary fatty acid composition could affect
skeletal health.
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